By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Fox Chase Cancer Center 

333 Cottman Avenue

Philadelphia  Pennsylvania  19111-2497  U.S.A.
Phone: 888-369-2427 Fax: n/a




Company News
Oncoceutics Release: Clinical Trial For ONC201 Begins At Fox Chase Cancer Center 11/30/2015 1:02:50 PM
Accutest And Fox Chase Cancer Center - Temple Health Form Strategic Partnership On Clinical Trials For Oncology 11/30/2015 6:40:46 AM
Fox Chase Cancer Center Release: Mutations That Predict Response To Therapy Could Guide Treatment Of Bladder Cancer 8/5/2015 10:05:32 AM
Horizon Pharma (HZNP) Announces Collaboration With Fox Chase Cancer Center To Study ACTIMMUNE (Interferon Gamma-1b) In Combination With PD-1/PD-L1 Inhibitors In Various Forms Of Cancer 7/27/2015 11:35:20 AM
Fox Chase Cancer Center To Conduct ONC201 Dose Intensification Trial 7/20/2015 9:39:34 AM
Caris Life Sciences Designates Fox Chase Cancer Center A Caris Center Of Excellence In Precision Medicine 6/10/2015 7:33:32 AM
RayBiotech Announces Partnership With Fox Chase Cancer Center 12/18/2013 9:52:10 AM
N-of-One, Inc. Partners With Fox Chase Cancer Center to Provide Molecular Interpretation and Treatment Strategy Analysis for Patients Receiving CancerCode-45TM DNA Sequencing 2/21/2013 9:20:00 AM
The Cancer Genome Institute at Fox Chase Cancer Center is Among the First in the Nation to Offer Advanced Cancer Patients a Blueprint of Their Cancer Genes 1/7/2013 9:53:58 AM
Fox Chase Cancer Center Researchers Develop Novel 3-D Culture System for Inflammatory Breast Cancer 12/10/2012 8:04:45 AM